develops innovative medical devices designed for phototherapy. The company is the owner of a unique and proprietary technology: the emission of light through woven optic fibers, the Fabric of Light (Lightex®). This technology was originally developed by Brochier Technologies (www.brochiertechnologies.com
) with which NeoMedLight shares the overall ownership. NeoMedLight has the exclusivity in healthcare.
The company has initially conceived and developed a fiber-optic phototherapy device to treat neonatal jaundice
; Further therapeutic indications that would benefit from the Fabric of Light may include mucositis
, wound healing/tissue regeneration
, as well as pain management.
The objective of NeoMedLight® is to bring the innovation to all therapeutic fields in which it will benefit patients and healthcare providers.
NeoMedLight is certified ISO 13485